Management of Severe Hypocalcemia (Calcium 1.3 mmol/L)
This patient requires immediate intravenous calcium replacement given the critically low calcium level of 1.3 mmol/L, which is life-threateningly low regardless of albumin status.
Immediate Assessment and Stabilization
Clinical Evaluation
- Assess for symptoms of severe hypocalcemia immediately: paresthesias, Chvostek's and Trousseau's signs, bronchospasm, laryngospasm, tetany, seizures, or cardiac arrhythmias 1
- Obtain ECG monitoring to detect QT prolongation and arrhythmias, particularly if ionized calcium is <0.8 mmol/L 2
- Check ionized calcium level urgently if not already done, as this is the biologically active form and guides therapy 2, 3
- Measure albumin, magnesium, phosphate, creatinine, and PTH to identify underlying causes and guide treatment 1, 4
Critical Context
A calcium of 1.3 mmol/L is severely low even before albumin correction. Normal total calcium ranges from 2.10-2.54 mmol/L 1. This level is associated with increased mortality, coagulopathy, and cardiovascular dysfunction in critically ill patients 2, 5, 6.
Immediate IV Calcium Replacement
Choice of Calcium Salt
- Calcium chloride is preferred over calcium gluconate for severe hypocalcemia 2, 7
- Calcium chloride provides 270 mg elemental calcium per 10 mL of 10% solution (27 mg/mL) 7
- Calcium gluconate provides only 90 mg elemental calcium per 10 mL of 10% solution (9.3 mg/mL) 8
- Calcium chloride releases ionized calcium faster, especially important if liver dysfunction is present 2
Initial Dosing Strategy
- Start with 1-2 mg elemental calcium per kg body weight per hour as continuous IV infusion 2
- For a 70 kg patient, this equals approximately 70-140 mg elemental calcium per hour
- Administer via secure central or deep vein to minimize risk of extravasation 7
- Do not exceed 1 mL/min administration rate for bolus dosing to avoid cardiac complications 7
Alternative Bolus Approach
- If using calcium chloride: 10-20 mL of 10% calcium chloride (270-540 mg elemental calcium) given slowly IV over 10-20 minutes 7
- If using calcium gluconate: 1,000-2,000 mg calcium gluconate (93-186 mg elemental calcium) IV 8
- May repeat every 1-3 hours based on response 7
Monitoring During Acute Treatment
Frequency of Calcium Monitoring
- Measure ionized calcium every 1-4 hours during continuous infusion 2, 8
- Measure ionized calcium every 4-6 hours during intermittent bolus therapy 2, 8
- Target ionized calcium >0.9 mmol/L to support cardiovascular function and coagulation 2
- Optimal target is ionized calcium 1.15-1.36 mmol/L (normal range) 2
Cardiac Monitoring
- Continuous ECG monitoring is essential, especially if patient is on cardiac glycosides 8
- Watch for arrhythmias, particularly with rapid administration 8, 7
- If on digoxin or other cardiac glycosides, give calcium very slowly in small amounts as synergistic arrhythmias can occur 8
Addressing Underlying Causes
Check for Hypomagnesemia
- Measure serum magnesium immediately as hypomagnesemia is present in 28% of hypocalcemic ICU patients and prevents calcium correction 5
- Correct magnesium deficiency before expecting full calcium normalization 1, 4
Assess Renal Function
- If renal impairment is present (CKD stage 3-5), initiate at the lower end of dosage range 8
- Monitor calcium more frequently (every 4 hours) in renal impairment 8
- Check PTH levels as secondary hyperparathyroidism may be contributing 1
Evaluate for Vitamin D Deficiency
- Measure 25-hydroxyvitamin D levels 1, 4
- If <30 ng/mL, plan for vitamin D supplementation once acute phase is managed 1
Transition to Maintenance Therapy
When to Transition
- Once ionized calcium stabilizes above 0.9 mmol/L and patient can take oral medications 2
- Continue IV calcium at reduced rate while initiating oral therapy to ensure smooth transition 2
Oral Calcium Supplementation
- Calcium carbonate 1-2 grams three times daily (provides 400-800 mg elemental calcium per dose) 2
- Total elemental calcium intake should not exceed 2,000 mg/day 1
Vitamin D Therapy
- Consider adding calcitriol up to 2 μg/day to enhance intestinal calcium absorption 2
- In CKD patients with PTH >300 pg/mL, active vitamin D sterols are indicated 1
Critical Safety Considerations
Extravasation Risk
- Calcinosis cutis can occur with or without extravasation of IV calcium 8
- Tissue necrosis, ulceration, and secondary infection are serious complications 8
- If extravasation occurs, immediately discontinue infusion at that site and treat locally 8
Drug Incompatibilities
- Do not mix calcium with phosphate-containing or bicarbonate-containing fluids as precipitation will occur 8
- Calcium channel blockers may have reduced efficacy during calcium administration 8
Special Populations
- In elderly patients, start at the lower end of dosage range 8
- Aluminum content (up to 400 mcg/L) may accumulate in renal failure 8
Prognosis and Follow-up
- Hypocalcemia in critically ill patients is associated with 44% mortality versus 17% in normocalcemic patients 5
- Low ionized calcium at admission predicts increased mortality, massive transfusion needs, and coagulopathy 2
- Continue monitoring until ionized calcium consistently stable in normal range 2
- Once stable, monitor corrected total calcium and phosphorus at least every 3 months 1